Predicting stomach retention risk before sedated endoscopy
Part of Cancer, Digestive system clinical trials.
This study is building a tool to predict if a patient's stomach will empty normally before a sedated upper endoscopy (gastroscopy). It tests risk factors that help doctors plan safer procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a sedated upper endoscopy or both upper and lower endoscopy.
- You do not have active bleeding in the upper digestive tract (like vomiting blood or black stools) in the past 24 hours.
- You are not having an emergency endoscopy.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a stomach mapping device (BSGM) to see how a prokinetic medication changes stomach activity in people with gastroparesis or functional dyspepsia. If you qualify, you'll have two non-invasive recordings—one before and one during your treatment.
This study uses endoscopy findings to predict if high-risk patients will develop stomach cancer or precancerous changes. It aims to improve follow-up care for people with signs of infection or stomach lining thinning.
This study looks at whether pausing GLP-1 agonist medications (like Ozempic or Trulicity) for two weeks before an upper endoscopy can reduce the chance of food staying in the stomach during the procedure. It may help people who take these diabetes medicines and need a routine endoscopy.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
This study uses ultrasound to see how quickly your stomach empties after a meal. It aims to learn more about normal stomach function in healthy adults.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
Hear when a new Gastric Cancer Stage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.